Market accessOfficial
Update of the list of innovative medicines as of 31 October 2026 (AIFA)
🇮🇹 AIFA · Tue 03 Nov 2026
AIFA has published its updated list of medicines that its Scientific and Economic Commission (CSE) has judged to meet the criterion of therapeutic innovativeness, with the list current to 31 October 2026. The status is relevant to market access and reimbursement, so MAHs should check whether their products are listed.
Summary written by VigiEye from the official notice. AI-assisted; check the source before acting.
More Market access
All →
Market accessCompany releaseMedicare begins paying for Lucid's EsoGuard as PAVmed's Veris nears FDA 510(k) filing
🇺🇸 PAVmed Inc. (PAVM) · Fri 13 Nov 2026
Market accessOfficialDenmark updates Voltabak eye drop supply notice, with shortage expected to run to mid-May 2027
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialMethergin 0.2 mg/ml injection withdrawn from Danish market, DKMA reports
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialDenmark updates import window for estradiol 25 microgram patches in supply failure
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialDKMA updates Vivelle Dot 37.5 supply notice: shortage expected to last until end of December
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialIntersurgical breathing systems: connectors can detach from Smoothbore tube, IGJ posts safety notice
🇳🇱 IGJ · Thu 12 Nov 2026